Quick Answer
LifeMD, Inc. reported Diluted EPS of $0.03 per share (loss) for fiscal year 2017.
LifeMD, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2017 | -$0.03 | +0.0% |
| 2016 | -$0.03 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2017 | -$0.02 | -100.0% | -200.0% |
| June 30, 2017 | $0.02 | +300.0% | +300.0% |
| September 30, 2016 | -$0.01 | -100.0% | +0.0% |
| June 30, 2016 | -$0.01 | -100.0% | -100.0% |
| March 31, 2016 | $32010375.00 | +2.1% | +4.4% |
| September 30, 2015 | $30650000.00 | — | +0.0% |
| June 30, 2015 | $30650000.00 | — | -2.3% |
| March 31, 2015 | $31363306.00 | — | — |
- LifeMD, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2016–2017 period, LifeMD, Inc.’s diluted eps has grown by 0.0% (from $0.03 per share (loss) to $0.03 per share (loss)).
- The most recent figure is from LifeMD, Inc.’s fiscal year 2017 report (Form 10-K), filed with the SEC on April 2, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: